Compare Enveric Biosciences Inc (ENVB) vs Toronto-Dominion Bank (TD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Toronto-Dominion Bank — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while Toronto-Dominion Bank trades at $121.35 (market cap $200.48B). The key difference: Toronto-Dominion Bank is far larger — about 32335.5× Enveric Biosciences Inc's market cap, and Toronto-Dominion Bank pays a 2.63% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | TD | |
|---|---|---|
Market Cap | $6.20M | $200.48B |
Sector | Health | Financials |
52-Week High | $17.40 | $124.80 |
52-Week Low | $1.27 | $72.85 |
Enterprise Value | $1.30M | — |
Dividend Yield | — | 2.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Toronto-Dominion Bank
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →
